Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

APC selectively mediates response to chemotherapeutic agents in breast cancer.

VanKlompenberg MK, Bedalov CO, Soto KF, Prosperi JR.

BMC Cancer. 2015 Jun 7;15:457. doi: 10.1186/s12885-015-1456-x.

2.

Meta-analysis of the association between APC promoter methylation and colorectal cancer.

Ding Z, Jiang T, Piao Y, Han T, Han Y, Xie X.

Onco Targets Ther. 2015 Jan 19;8:211-22. doi: 10.2147/OTT.S75827. eCollection 2015.

3.

Chemotherapy induced microsatellite instability and loss of heterozygosity in chromosomes 2, 5, 10, and 17 in solid tumor patients.

Kamat N, Khidhir MA, Hussain S, Alashari MM, Rannug U.

Cancer Cell Int. 2014 Nov 30;14(1):118. doi: 10.1186/s12935-014-0118-4. eCollection 2014.

4.

Clinical application of genetics in management of colorectal cancer.

Kim ER, Kim YH.

Intest Res. 2014 Jul;12(3):184-93. doi: 10.5217/ir.2014.12.3.184. Epub 2014 Jul 25. Review.

5.

PELP1 suppression inhibits colorectal cancer through c-Src downregulation.

Ning Z, Zhang Y, Chen H, Wu J, Song T, Wu Q, Liu F.

Oxid Med Cell Longev. 2014;2014:193523. doi: 10.1155/2014/193523. Epub 2014 May 22.

6.

Molecular profile of colorectal cancer in Indonesia: is there another pathway?

Abdullah M, Sudoyo AW, Utomo AR, Fauzi A, Rani AA.

Gastroenterol Hepatol Bed Bench. 2012 Spring;5(2):71-8. Review.

7.

Combined genotoxic effects of a polycyclic aromatic hydrocarbon (B(a)P) and an heterocyclic amine (PhIP) in relation to colorectal carcinogenesis.

Jamin EL, Riu A, Douki T, Debrauwer L, Cravedi JP, Zalko D, Audebert M.

PLoS One. 2013;8(3):e58591. doi: 10.1371/journal.pone.0058591. Epub 2013 Mar 6.

8.

Dysregulation of microRNAs in colonic field carcinogenesis: implications for screening.

Kunte DP, DelaCruz M, Wali RK, Menon A, Du H, Stypula Y, Patel A, Backman V, Roy HK.

PLoS One. 2012;7(9):e45591. doi: 10.1371/journal.pone.0045591. Epub 2012 Sep 25.

9.

High incidence of microsatellite instability and loss of heterozygosity in three loci in breast cancer patients receiving chemotherapy: a prospective study.

Kamat N, Khidhir MA, Jaloudi M, Hussain S, Alashari MM, Al Qawasmeh KH, Rannug U.

BMC Cancer. 2012 Aug 28;12:373. doi: 10.1186/1471-2407-12-373.

10.

Adenomatous polyposis coli interacts with flap endonuclease 1 to block its nuclear entry and function.

Jaiswal AS, Armas ML, Izumi T, Strauss PR, Narayan S.

Neoplasia. 2012 Jun;14(6):495-508.

11.

Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance.

Luo Y, Ellis LZ, Dallaglio K, Takeda M, Robinson WA, Robinson SE, Liu W, Lewis KD, McCarter MD, Gonzalez R, Norris DA, Roop DR, Spritz RA, Ahn NG, Fujita M.

J Invest Dermatol. 2012 Oct;132(10):2440-50. doi: 10.1038/jid.2012.161. Epub 2012 May 24.

12.

ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics.

Levidou G, Saetta AA, Gigelou F, Karlou M, Papanastasiou P, Stamatelli A, Kavantzas N, Michalopoulos NV, Agrogiannis G, Patsouris E, Korkolopoulou P.

World J Surg Oncol. 2012 Feb 29;10:47. doi: 10.1186/1477-7819-10-47.

13.

Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population.

Syed Sameer A, Shah ZA, Abdullah S, Chowdri NA, Siddiqi MA.

Hum Genomics. 2011 Jul;5(5):441-52.

14.

MOLECULAR BASIS OF HEREDITARY COLORECTAL CANCER.

Hughes MR, Huang EH.

Semin Colon Rectal Surg. 2011 Jun 1;22(2):65-70.

15.

DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer.

Jaiswal AS, Banerjee S, Aneja R, Sarkar FH, Ostrov DA, Narayan S.

PLoS One. 2011 Feb 2;6(2):e16691. doi: 10.1371/journal.pone.0016691.

16.

Assembly of the base excision repair complex on abasic DNA and role of adenomatous polyposis coli on its functional activity.

Jaiswal AS, Narayan S.

Biochemistry. 2011 Mar 22;50(11):1901-9. doi: 10.1021/bi102000q. Epub 2011 Feb 4.

17.

A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells.

Jaiswal AS, Banerjee S, Panda H, Bulkin CD, Izumi T, Sarkar FH, Ostrov DA, Narayan S.

Mol Cancer Res. 2009 Dec;7(12):1973-83. doi: 10.1158/1541-7786.MCR-09-0309. Epub 2009 Dec 8.

18.

Amino acid Asp181 of 5'-flap endonuclease 1 is a useful target for chemotherapeutic development.

Panda H, Jaiswal AS, Corsino PE, Armas ML, Law BK, Narayan S.

Biochemistry. 2009 Oct 27;48(42):9952-8. doi: 10.1021/bi9010754.

19.

Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas.

Rollison DE, Helzlsouer KJ, Lee JH, Fulp W, Clipp S, Hoffman-Bolton JA, Giuliano AR, Platz EA, Viscidi RP.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1515-23. doi: 10.1158/1055-9965.EPI-08-1119. Epub 2009 Apr 21.

20.

Diet and epigenetics in colon cancer.

Nystrom M, Mutanen M.

World J Gastroenterol. 2009 Jan 21;15(3):257-63.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk